PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel.
ANNAPOLIS, Md., Nov. 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has signed an agreement with Medison Pharma Ltd., to commercialize its biodefense products in Israel. "The need for advanced medical...

PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference.
ANNAPOLIS, Md., Nov. 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (NYSE Alternext US: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New...

PharmAthene to Present at the 7th Annual BIO Investor Forum in San Francisco.
ANNAPOLIS, Md., Oct. 23 /PRNewswire-FirstCall/ -- PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the 7th Annual BIO Investor Forum in San Francisco on Thursday, October 30, 2008...

Pharmathene Reports Third Quarter 2008 Financial and Operational Results.
ANNAPOLIS, Md., Nov. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September 30, 2008. For the third quarter of 2008, PharmAthene...

PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008.
ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the third quarter of 2008 will be released on Thursday, November 13, 2008. PharmAthene management will be hosting a conference call...

Follow the leader: in reporting on weapons of mass destruction, the media too often take their cues from the president.
I showed "All the President's Men" in my journalism ethics class the other day, and the lesson that most students took away from the movie and the related Watergate case study was that good journalism is another name for dogged persistence, that ferreting out the facts is the essential...

Israel On Iran.
Some Israeli officials and commentators during the week hinted the Jewish state could stage a military operation against Iran which, GCC officials warned, could eventually drag the US into a wider confrontation. At a White House news conference on Dec. 4, President Bush did not rule out...

Phantoms over Syria: eveything Israel wants you to know about its secret airstrike.
ON SEPT. 6, Israeli F-15s and F-16s attacked a site near Dayr az-Zawr in northern Syria, though the strike wasn't confirmed for nearly two weeks. The Washington Post reported on Sept. 13 that according to a former Israeli official, "it was an attack against a facility capable of making...

Govt to check export of sensitive material.
Byline: Gireesh Chandra Prasad & G Ganapathy Subramaniam NEW DELHI: Exporters will soon be subjected to more rigorous checks depending on who their customers are as the government is all set to project its credentials in preventing the proliferation of chemical, biological and nuclear weapons and their...

Miller brouhaha: the New York Times' Judith Miller has been pummelled unmercifully for her reporting on the search for weapons of mass destruction in Iraq. But coverage of this murky subject has hardly been the finest hour for the news media in general.
As the war in Iraq has turned into a grueling occupation, the question of Saddam Hussein's weapons of mass destruction persists. To investigate that question, there would seem to be no better-qualified reporter on Earth than Judith Miller of the New York Times. Miller is a genuine...